CAMERA, MARINA
 Distribuzione geografica
Continente #
EU - Europa 12.927
NA - Nord America 7.735
AS - Asia 5.527
SA - Sud America 522
AF - Africa 74
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 39
Totale 26.868
Nazione #
US - Stati Uniti d'America 7.563
GB - Regno Unito 4.762
CN - Cina 2.240
IT - Italia 2.154
DE - Germania 1.686
SE - Svezia 1.242
SG - Singapore 1.149
RU - Federazione Russa 790
TR - Turchia 608
KR - Corea 467
IE - Irlanda 451
IN - India 443
NL - Olanda 406
BR - Brasile 371
UA - Ucraina 341
FR - Francia 315
EU - Europa 284
FI - Finlandia 254
PL - Polonia 170
ID - Indonesia 153
CA - Canada 152
HK - Hong Kong 134
CO - Colombia 87
DK - Danimarca 68
JP - Giappone 63
PH - Filippine 61
GR - Grecia 58
VN - Vietnam 55
BE - Belgio 41
AT - Austria 38
AU - Australia 36
ES - Italia 25
CH - Svizzera 23
RO - Romania 23
CL - Cile 22
PK - Pakistan 21
EG - Egitto 19
NO - Norvegia 19
IL - Israele 14
IR - Iran 14
MX - Messico 14
CZ - Repubblica Ceca 13
TW - Taiwan 13
AR - Argentina 12
MA - Marocco 11
ZA - Sudafrica 11
MY - Malesia 10
PE - Perù 10
BD - Bangladesh 9
AZ - Azerbaigian 8
EC - Ecuador 8
IQ - Iraq 8
NZ - Nuova Zelanda 8
NP - Nepal 7
TH - Thailandia 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
PT - Portogallo 6
SC - Seychelles 6
SI - Slovenia 6
TN - Tunisia 6
VE - Venezuela 6
RS - Serbia 5
SA - Arabia Saudita 5
DZ - Algeria 4
KE - Kenya 4
KZ - Kazakistan 4
LU - Lussemburgo 4
LV - Lettonia 4
NG - Nigeria 4
BG - Bulgaria 3
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
LK - Sri Lanka 3
OM - Oman 3
BO - Bolivia 2
CM - Camerun 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
JO - Giordania 2
MD - Moldavia 2
ML - Mali 2
MN - Mongolia 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
IS - Islanda 1
LB - Libano 1
Totale 27.109
Città #
Southend 4.513
Chandler 847
Milan 749
Singapore 744
Seattle 647
Princeton 534
Wilmington 492
Dublin 442
Beijing 425
Frankfurt am Main 418
Ashburn 410
Hanover 365
Fairfield 323
Council Bluffs 317
Mountain View 309
Redmond 287
Santa Clara 247
Nanjing 245
Dearborn 210
Sakarya 197
Woodbridge 175
Des Moines 168
Ann Arbor 167
Jacksonville 158
Boardman 152
Bengaluru 141
Cambridge 118
Jinan 115
Warsaw 113
Centro 112
Somerville 104
Shenyang 101
Jakarta 96
Hong Kong 93
Andover 91
Houston 89
Seoul 87
Serra 86
Hangzhou 85
Berlin 81
Bogotá 81
Shanghai 81
Changsha 71
Nanchang 68
Bitonto 62
Ottawa 61
Rome 60
Guangzhou 59
Phoenix 59
Tianjin 58
Zhengzhou 57
Hebei 56
Eitensheim 54
Grafing 54
Munich 53
Redwood City 53
Toronto 51
Athens 50
Jiaxing 50
Medford 46
Los Angeles 44
Bühl 40
Helsinki 40
Taizhou 37
Ningbo 36
San Diego 34
Brussels 33
Fuzhou 33
Pisa 30
Turin 30
Hamburg 29
Istanbul 28
London 28
Padova 27
São Paulo 26
Roxbury 25
Nuremberg 24
Cangzhou 23
Kunming 23
Wuhan 23
Brescia 21
Norwalk 21
Odernheim 21
Vienna 21
Lanzhou 20
New York 20
Polska 19
Costa Mesa 18
Chicago 17
Dong Ket 17
Falls Church 17
Bologna 16
Central District 16
Haikou 16
Hefei 16
Jeonju 16
Bergamo 15
Mainz 15
Matsudo 15
Verona 15
Totale 17.202
Nome #
The Role of Tissue Factor in Atherothrombosis and Coronary Artery Disease : Insights into Platelet Tissue Factor 422
Impact of angiotensin-converting enzyme inhibition on platelet tissue factor expression in stroke-prone rats 302
PCSK9 induces a pro-inflammatory response in macrophages 277
PCSK9 as a Positive Modulator of Platelet Activation 272
MicroRNA-222 Regulates Melanoma Plasticity 250
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 240
D-dimer is associated with arterial and venous coronary artery bypass graft occlusion 239
Tissue factor gene promoter haplotype associates with carotid intima-media thickness in subjects in cardiovascular risk prevention 231
The MIAMI Study (Markers of inflammation and Atorvastatin effect in previous myocardial infarction) : results of a prospective, multicenter study 208
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics : Effects of Improved Dosing Regimens 194
E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients : the baseline findings of the MIAMI study 191
An Intense and Short-Lasting Burst of Neutrophil Activation Differentiates Early Acute Myocardial Infarction from Systemic Inflammatory Syndromes 191
Lipoproteine aterogene e sintesi di PAI-1 da parte di cellule endoteliali 191
Do methodological differences account for the current controversy on tissue factor expression in platelets? 189
Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery 186
Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients 186
Repurposing of drugs approved for cardiovascular diseases : Opportunity or mirage? 182
Antithrombotic and anti-inflammatory properties of rosuvastatin in cultured human endothelial cells 180
Drug repurposing in cardiovascular diseases : Opportunity or hopeless dream? 180
Biological profile of monocyte-derived macrophages in coronary heart disease patients : implications for plaque morphology 179
Fibrillar collagen inhibits cholesterol biosynthesis in human aortic smooth muscle cells 178
Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL 176
Endothelial Dysfunction in Patients with Severe Mitral Regurgitation 176
Nuove acquisizioni sull'aterosclerosi: placca vulnerabile : relazione su invito 175
Lipoproteine aterogene e trombosi: aspetti cellulari 174
Biochemical and mechanical properties of intraluminal thrombus from human abdominal aortic aneurysm 173
A standardized stimulus augment CRP similarly in patients with a history of stable or unstable 169
Synthesis of long-chain polyunsaturated fatty acids is inhibited in vivo in hypercholesterolemic rabbits and in vitro by oxysterols 168
Platelet behaviour in patients with drug-eluting stents after thienopyridine treatment discontinuation 165
The ATROCAP Study: atorvastatin and the thrombogenicity of carotid atherosclerotic plaque 162
The MIAMI Study (Markers of inflammation and Atorvastatin effect in previous myocardial infarction): Results of a prospective, open-label, multicenter Study. 161
Inflammatory Markers and Carotid Intima Media Thickness (C-IMT) in Stable IHD Patients 159
null 159
Vitamin d plasma levels and in-hospital and 1-year outcomes in acute coronary syndromes : a prospective study 156
The MIAMI study (Markers of Inflammation and Atorvastatin effect in previous Myocardial Infarction): results of a prospective, open-label, multicenter study 155
Distinct roles for PAR1- and PAR2-mediated vasomotor modulation in human arterial and venous conduits 152
PCSK9 promotes arterial medial calcification 152
Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study 150
E-Selettina e l’inibitore del fattore tissutale (TFPI) correlano con l’inspessimento medio-intimale carotideo (C-IMT) in pazienti con malattia ischemica coronarica in fase di stabilità clinica: risultati basali dello Studio MIAMI 148
Digital PCR for high sensitivity viral detection in false-negative SARS-CoV-2 patients 148
Vascular thrombogenicity induced by progressive LDL oxidation : protection by antioxidants 147
Effetti di Atorvastatina su markers solubili aterosclerosi carotidea : Risultati dello Studio MIAMI 146
Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis 145
Diversity and similarity in signaling events leading to rapid COX-2 synthesis by PMA and TNFin human endothelial cells 144
Triglycerides and the fibrinolytic system 143
Atherosclerotic plaque as a therapeutic target. The ATROCAP Study (Atorvastatin and Thrombogenicity of Carotid Atherosclerotic Plaque). 142
Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis 142
Proteome of platelets in patients with coronary artery disease 141
Chemotactic effect of prorenin on human aortic smooth muscle cells : a novel function of the (pro)renin receptor 141
Oxidized phospholipids inhibit cyclooxygenase-2 in human macrophages via nuclear factor-kappaB/IkappaB- and ERK2-dependent mechanisms 140
Effects of native and modified low density lipoproteins on functional and biochemical aspects of cells involved in the thrombotic process 140
Tissue factor in patients with acute coronary syndromes : expression in platelets, leukocytes, and platelet-leukocyte aggregates 138
Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up 138
Triglycerides and the fibrinolytic system 137
PCSK9 Involvement in Aortic Valve Calcification 137
Nonrheumatic calcific aortic stenosis : an overview from basic science to pharmacological prevention 136
Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDL 136
Platelet activation in patients undergoing carotid artery stenting procedure 134
Opposite changes of ADAMTS-13 and von Willebrand factor after cardiac surgery 133
PLATELET PROTHROMBOTIC AND TRANSCRIPTOMIC PROFILE IN CAD PATIENTS WITH TYPE-2 DIABETES MELLITUS 133
Expression of alternatively spliced tissue factor in human endothelial cells : induction by inflammatory stimuli and modulation by heparins 131
Soluble E-Selectin and tissue factor pathway inhibitor, but not C-reactive protein, correlate with carotid intima-media thickness (C-IMT) in stable coronary patients: the baseline data of the MIAMI Study 131
Atherogenic lipoproteins and PAI-1 synthesis by endothelial-cells 131
The role of tissue factor and P-selectin in the procoagulant response that occurs in the first month after on-pump and off-pump coronary artery bypass grafting 130
Comparative transcript profiling of human platelets from patients with stable angina and acute coronary syndromes 130
Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery 130
Cerebral derailment after myocardial infarct: mechanisms and effects of the signaling from the ischemic heart to brain 130
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation 129
Plasminogen activator inhibitor type-1 mRNA expression is increased by triglyceride rich lipoproteins in human hepatoma cells 129
Lipoproteine aterogene ed endotelio vascolare 127
Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells 127
Preparazioni piastriniche per studi di trascrittomica: caccia al leucocita 126
E-selectin and TFPI are associated with carotid intima-media thickness in stable coronary patients : the baseline findings of the MIAMI Study 125
Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon 125
Distinct roles for PAR-1 and PAR-2 mediated vasomotor modulation in human arterial and venous conduits used in coronary artery bypass surgery 125
REGULATION OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 BY ACETYL-LDL IN HUMAN UMBIUCAL VEIN ENDOTIIELIAL CELLS 125
Multidetector computed tomography (mdct): able to define the plaque composition as assessed by histology? 124
Titolare di un progetto di Ricerca finanziato dalla Fondazione Italo Monzino dal titolo "Nuovi meccanismi patogenetici delle sindromi coronariche acute: Identificazione dei meccanismi molecolari coinvolti nelle alterazioni del trascrittoma piastrinico osservate nella malattia coronarica 124
Hyperlipidemias and the fibrinolytic system 124
ACE-Inhibition Benefit on Lung Function in Heart Failure is Modulated by ACE Insertion/Deletion Polymorphism 124
Effect of triglycerides and triglyceride rich lipoproteins on fibrinolytic system 123
Gene expression profiling reveals multiple differences in platelets from patients with stable angina or non-ST elevation acute coronary syndrome 122
Overcoming limitations of current antiplatelet drugs: a concerted effort for more profitable strategies of intervention 122
Effects of triglyceride rich lipoproteins on the synthesis of plasminogen activator inhibitor 1 (PAI-1) by HepG2 cells 122
Effetto delle VLDL sull'espressione di mRNA per il PAI-1 in cellule HepG2 122
Distinct roles for PAR1 and 2-mediated vasomotor modulation in human arterial and venous conduits used in coronary artery by pass surgery 122
Eicosanoids and Their Drugs in Cardiovascular Diseases : Focus on Atherosclerosis and Stroke 121
An increased prothrombotic state lasts up to one month after on-pump and off-pump coronary surgery 121
Association of tissue factor A-603G genotype with carotid intima-media thickness in subjects in cardiovascular risk prevention 120
Triglycerides and the fibrinolytic system: in vitro regulation of the synthesis of plasminogen activator type 1 by triglyceride-rich lipoproteins in HepG2 cells 120
Patients with a history of stable or unstable coronary heart disease have different acute phase responses to an inflammatory stimulus 119
Hypertriglyceridemia and regulation of fibrinolytic activity 119
Effect of atorvastatin on coagulation and inflammatory variables in patients with bilateral carotid stenosis. 119
15-deoxy-D12,14-prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade. 119
Rosuvastatin reduces inflammation and atherothrombosis in apoE-deficient mice 118
Carotid versus Coronary Stent Revascularization: Comparison of the Platelet Activation Profile 118
V Congresso monotematico della SIF. Aterotrombosi: dalla ricerca di base alla clinica. Milano, 3-4 Novembre 2011. Organizzazione e segreteria scientifica. 118
Platelet behaviour after thienopyridine treatment discontinuation in patients with DES 117
Inflammatory Markers and C-IMT in Patients with Previous Myocardial Infarction. The Atorvastatin Effect . MIAMI Study 117
Platelet transcriptome profiling in stable angina and non-ST elevation acute coronary syndrome 117
Totale 15.482
Categoria #
all - tutte 89.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.475


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020644 0 0 0 0 0 0 0 0 0 410 136 98
2020/20212.802 127 256 221 85 246 235 124 121 316 155 739 177
2021/20223.061 239 118 139 127 243 289 253 205 277 281 373 517
2022/20233.539 551 308 266 397 374 690 106 198 350 52 158 89
2023/20242.290 83 164 140 226 491 164 82 101 65 128 321 325
2024/20253.793 225 540 152 505 525 233 238 599 329 447 0 0
Totale 28.671